Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioHarvest Sciences is a biotechnology company that has developed a proprietary plant cell biology platform called Bio-Plant CELLicitation. This technology allows for the production of specific active plant ingredients, such as polyphenols and antioxidants, in liquid bioreactors without the need to grow the entire plant. The company's flagship product, VINIA, is a red grape cell powder containing a complex of polyphenols including piceid resveratrol, designed to support cardiovascular health and blood flow. BioHarvest is also expanding its pipeline into the cannabis and hemp sectors, as well as pharmaceutical applications for its cell-based production method.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VINIA.